• Webinars
  • Cardio-Metabolic and Renal Diseases, MASH (NASH)
  • 27-06-2024

Webinar – Clinical consequences of the New MASLD Nomenclature

On the 27th of June, we organized the webinar: 'Clinical Consequences of the New MASLD Nomenclature' with guest speaker Prof. Maja Thiele.During this webinar, our speaker and hosts dived into the following topics:Is the MASLD nomeclature...

  • News
  • Cardio-Metabolic and Renal Diseases, MASH (NASH)

Metabolic dysfunction associated steatotic liver disease and the heart

Commentary by Dr. Marco Alings, MD PhD, Amphia Ziekenhuis, Breda; WCN, Utrecht; Scientific Officer at Julius ClinicalThe estimated prevalence of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) in the adult population is 31% ...

By: Sanne-Lotte van Barneveld
  • Cardio-Metabolic and Renal Diseases

Webinar – Getting GRIP on MASH after LITMUS

On March 12th, we organised the webinar: Getting GRIP on MASH after LITMUSDuring this webinar, our speaker and hosts explored the following topics:The usefulness of noninvasive diagnostic methods depends on the prevalence of the disease ...

A brand-new look!

We are excited to announce that Julius Clinical has a brand-new look and website as part of the ongoing evolution of our company’s brand.Why? Ever since its foundation in 2008, Julius Clinical has been based on a unique triangle of scientif...

By: Sanne-Lotte van Barneveld

Download

"*" indicates required fields

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Request for proposal

"*" indicates required fields

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
This field is for validation purposes and should be left unchanged.

Share

Twitter Facebook LinkedIn